Growth momentum SI-BONE shows solid revenue growth and expanding international demand, signaling a ripe environment for expanded distribution partnerships, clinical training programs, and value-based selling opportunities to accelerate adoption of the iFuse Implant System.

Procedure volume Rising U.S. and international procedure volumes present a clear gateway for field teams to engage spine surgeons with bundled offerings, training, and turnkey implant solutions to capture incremental cases and expand the customer base.

Product portfolio An expanded product portfolio increasing demand offers cross-sell and upsell chances to existing customers, including added implants or accessories that complement the iFuse system and improve patient outcomes.

Medtech visibility Strong presence at industry conferences and active investor communications indicate readiness for strategic partnerships, co-marketing arrangements, and potential channel collaborations to broaden market reach.

Financial health Narrowed losses with revenue growth and improved profitability metrics suggest a favorable environment for capital-efficient sales initiatives, clinical education investments, and performance-based partnerships.